33276023|t|Supplementation with gamma-glutamylcysteine (gamma-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD.
33276023|a|INTRODUCTION: The accumulation of oxidative stress, neuroinflammation and abnormal aggregation of amyloid beta-peptide (Abeta) have been shown to induce synaptic dysfunction and memory deficits in Alzheimer's disease (AD). Cellular depletion of the major endogenous antioxidant Glutathione (GSH) has been linked to cognitive decline and the development of AD pathology. Supplementation with gamma-glutamylcysteine (gamma-GC), the immediate precursor and the limiting substrate for GSH biosynthesis, can transiently augment cellular GSH levels by bypassing the regulation of GSH homeostasis. METHODS: In the present study, we investigated the effect of dietary supplementation of gamma-GC on oxidative stress and Abeta pathology in the brains of APP/PS1 mice. The APP/PS1 mice were fed gamma-GC from 3 months of age with biomarkers of apoptosis and cell death, oxidative stress, neuroinflammation and Abeta load being assessed at 6 months of age. RESULTS: Our data showed that supplementation with gamma-GC lowered the levels of brain lipid peroxidation, protein carbonyls and apoptosis, increased both total GSH and the glutathione/glutathione disulphide (GSH/GSSG) ratio and replenished ATP and the activities of the antioxidant enzymes (superoxide dismutase (SOD), catalase, glutamine synthetase and glutathione peroxidase (GPX)), the latter being a key regulator of ferroptosis. Brain Abeta load was lower and acetylcholinesterase (AChE) activity was markedly improved compared to APP/PS1 mice fed a standard chow diet. Alteration in brain cytokine levels and matrix metalloproteinase enzymes MMP-2 and MMP-9 suggested that gamma-GC may lower inflammation and enhance Abeta plaque clearance in vivo. Spatial memory was also improved by gamma-GC as determined using the Morris water maze. CONCLUSION: Our data collectively suggested that supplementation with gamma-GC may represent a novel strategy for the treatment and/or prevention of cognitive impairment and neurodegeneration.
33276023	21	43	gamma-glutamylcysteine	Chemical	MESH:C017341
33276023	45	53	gamma-GC	Chemical	MESH:C017341
33276023	87	99	inflammation	Disease	MESH:D007249
33276023	104	111	amyloid	Disease	MESH:C000718787
33276023	155	161	murine	Species	10090
33276023	171	173	AD	Disease	MESH:D000544
33276023	227	244	neuroinflammation	Disease	MESH:D000090862
33276023	295	300	Abeta	Gene	11820
33276023	328	348	synaptic dysfunction	Disease	MESH:C536122
33276023	353	368	memory deficits	Disease	MESH:D008569
33276023	372	391	Alzheimer's disease	Disease	MESH:D000544
33276023	393	395	AD	Disease	MESH:D000544
33276023	453	464	Glutathione	Chemical	MESH:D005978
33276023	466	469	GSH	Chemical	MESH:D005978
33276023	490	507	cognitive decline	Disease	MESH:D003072
33276023	531	533	AD	Disease	MESH:D000544
33276023	566	588	gamma-glutamylcysteine	Chemical	MESH:C017341
33276023	590	598	gamma-GC	Chemical	MESH:C017341
33276023	656	659	GSH	Chemical	MESH:D005978
33276023	707	710	GSH	Chemical	MESH:D005978
33276023	749	752	GSH	Chemical	MESH:D005978
33276023	854	862	gamma-GC	Chemical	MESH:C017341
33276023	887	892	Abeta	Gene	11820
33276023	924	927	PS1	Gene	19164
33276023	928	932	mice	Species	10090
33276023	942	945	PS1	Gene	19164
33276023	946	950	mice	Species	10090
33276023	960	968	gamma-GC	Chemical	MESH:C017341
33276023	1053	1070	neuroinflammation	Disease	MESH:D000090862
33276023	1075	1080	Abeta	Gene	11820
33276023	1172	1180	gamma-GC	Chemical	MESH:C017341
33276023	1209	1214	lipid	Chemical	MESH:D008055
33276023	1283	1286	GSH	Chemical	MESH:D005978
33276023	1295	1306	glutathione	Chemical	MESH:D005978
33276023	1307	1329	glutathione disulphide	Chemical	MESH:D019803
33276023	1331	1334	GSH	Chemical	MESH:D005978
33276023	1335	1339	GSSG	Chemical	MESH:D019803
33276023	1363	1366	ATP	Chemical	MESH:D000255
33276023	1442	1450	catalase	Gene	12359
33276023	1452	1472	glutamine synthetase	Gene	14645
33276023	1544	1555	ferroptosis	Disease	
33276023	1563	1568	Abeta	Gene	11820
33276023	1588	1608	acetylcholinesterase	Gene	11423
33276023	1610	1614	AChE	Gene	11423
33276023	1663	1666	PS1	Gene	19164
33276023	1667	1671	mice	Species	10090
33276023	1771	1776	MMP-2	Gene	17390
33276023	1781	1786	MMP-9	Gene	17395
33276023	1802	1810	gamma-GC	Chemical	MESH:C017341
33276023	1821	1833	inflammation	Disease	MESH:D007249
33276023	1846	1851	Abeta	Gene	11820
33276023	1914	1922	gamma-GC	Chemical	MESH:C017341
33276023	2036	2044	gamma-GC	Chemical	MESH:C017341
33276023	2115	2135	cognitive impairment	Disease	MESH:D003072
33276023	2140	2157	neurodegeneration	Disease	MESH:D019636
33276023	Positive_Correlation	MESH:D008569	11820
33276023	Association	MESH:D000544	11820
33276023	Association	MESH:C017341	17395
33276023	Positive_Correlation	MESH:C017341	MESH:D000255
33276023	Negative_Correlation	MESH:C017341	11820
33276023	Negative_Correlation	MESH:C017341	MESH:D000544
33276023	Association	MESH:C017341	17390
33276023	Negative_Correlation	MESH:C017341	MESH:D019636
33276023	Negative_Correlation	MESH:C017341	MESH:D008055
33276023	Positive_Correlation	MESH:C017341	12359
33276023	Positive_Correlation	MESH:C017341	MESH:D005978
33276023	Association	MESH:C017341	14645
33276023	Negative_Correlation	MESH:D005978	MESH:D000544
33276023	Negative_Correlation	MESH:D005978	MESH:D003072
33276023	Positive_Correlation	MESH:C017341	MESH:D019803
33276023	Negative_Correlation	MESH:C017341	MESH:C000718787
33276023	Positive_Correlation	MESH:C536122	11820
33276023	Negative_Correlation	MESH:C017341	11423
33276023	Negative_Correlation	MESH:C017341	MESH:D007249

